Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.
Advertisement
Articles by Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.
Advertisement
Latest Updated Articles
- Study Summary: DECIDE
June 29th 2018
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
3
Impact of Automated Insulin Delivery on Type 2 Diabetes Measures
4
Fifth Death Confirmed in NYC Legionnaires' Outbreak
5